Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miskowski

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2Henry J Breslin, Tamara A Miskowski, Michael J Kukla, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonistsYong Gong, J Kent Barbay, Edward S Kimball, et al.
Agents and Actions|September 1, 1992
Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liabilityS Wong, S J Lee, M R Frierson, et al.
Journal of Medicinal Chemistry|September 1, 1995
Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activitiesS J Lee, Y Konishi, D T Yu, et al.
Inorganic Chemistry|November 27, 2001
Electrostatic and conformational effects on the electronic structures of distortional isomers of a mixed-valence binuclear Cu complexS Franzen, V M Miskowski, A P Shreve, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)Henry J Breslin, Craig J Diamond, Robert W Kavash, et al.
Journal of Medicinal Chemistry|November 15, 2002
Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indolesHenry J Breslin, Tamara A Miskowski, Michael J Kukla, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluationJanet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
Bioorganic & Medicinal Chemistry|August 23, 2005
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonistsAlexey B Dyatkin, Yong Gong, Tamara A Miskowski, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2Henry J Breslin, Tamara A Miskowski, Michael J Kukla, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonistsYong Gong, J Kent Barbay, Edward S Kimball, et al.
Agents and Actions|September 1, 1992
Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liabilityS Wong, S J Lee, M R Frierson, et al.
Journal of Medicinal Chemistry|September 1, 1995
Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activitiesS J Lee, Y Konishi, D T Yu, et al.
Inorganic Chemistry|November 27, 2001
Electrostatic and conformational effects on the electronic structures of distortional isomers of a mixed-valence binuclear Cu complexS Franzen, V M Miskowski, A P Shreve, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)Henry J Breslin, Craig J Diamond, Robert W Kavash, et al.
Journal of Medicinal Chemistry|November 15, 2002
Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indolesHenry J Breslin, Tamara A Miskowski, Michael J Kukla, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluationJanet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, et al.
Journal of Medicinal Chemistry|October 1, 2004
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disordersHenry J Breslin, Tamara A Miskowski, Bryan M Rafferty, et al.
Bioorganic & Medicinal Chemistry|August 23, 2005
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonistsAlexey B Dyatkin, Yong Gong, Tamara A Miskowski, et al.
Pageof 4